Similar articles for PMID: 31254971

Year	Number of Results
2004	1
2007	4
2008	4
2009	5
2010	5
2011	5
2012	6
2013	3
2014	8
2015	6
2016	8
2017	6
2018	18
2019	14
2020	6
2021	4
2022	5
2023	1
2024	0

1

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder.

Thase ME, Stanford AD, Memisoglu A, Martin W, Claxton A, Bodkin JA, Trivedi MH, Fava M, Yu M, Pathak S. Thase ME, et al. Neuropsychopharmacology. 2019 Dec;44(13):2268-2276. doi: 10.1038/s41386-019-0451-3. Epub 2019 Jun 29. Neuropsychopharmacology. 2019. PMID: 31254971 Free PMC article. Clinical Trial.

2

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.

Fava M, Thase ME, Trivedi MH, Ehrich E, Martin WF, Memisoglu A, Nangia N, Stanford AD, Yu M, Pathak S. Fava M, et al. Mol Psychiatry. 2020 Jul;25(7):1580-1591. doi: 10.1038/s41380-018-0284-1. Epub 2018 Oct 29. Mol Psychiatry. 2020. PMID: 30374191 Free PMC article. Clinical Trial.

3

Evaluation of opioid modulation in major depressive disorder.

Ehrich E, Turncliff R, Du Y, Leigh-Pemberton R, Fernandez E, Jones R, Fava M. Ehrich E, et al. Neuropsychopharmacology. 2015 May;40(6):1448-55. doi: 10.1038/npp.2014.330. Epub 2014 Dec 18. Neuropsychopharmacology. 2015. PMID: 25518754 Free PMC article. Clinical Trial.

4

Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial.

Pathak S, Vince B, Kelsh D, Shram MJ, Setnik B, Lu H, Nangia N, Stanford AD, Ehrich E. Pathak S, et al. J Clin Pharmacol. 2019 Feb;59(2):206-217. doi: 10.1002/jcph.1280. Epub 2018 Aug 13. J Clin Pharmacol. 2019. PMID: 30102427 Clinical Trial.

5

Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.

Fava M, Memisoglu A, Thase ME, Bodkin JA, Trivedi MH, de Somer M, Du Y, Leigh-Pemberton R, DiPetrillo L, Silverman B, Ehrich E. Fava M, et al. Am J Psychiatry. 2016 May 1;173(5):499-508. doi: 10.1176/appi.ajp.2015.15070921. Epub 2016 Feb 12. Am J Psychiatry. 2016. PMID: 26869247 Clinical Trial.

6

Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).

Zajecka JM, Stanford AD, Memisoglu A, Martin WF, Pathak S. Zajecka JM, et al. Neuropsychiatr Dis Treat. 2019 Apr 4;15:795-808. doi: 10.2147/NDT.S199245. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31040679 Free PMC article.

7

Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat.

Smith KL, Cunningham JI, Eyerman DJ, Dean RL 3rd, Deaver DR, Sanchez C. Smith KL, et al. Neuropharmacology. 2019 Mar 1;146:316-326. doi: 10.1016/j.neuropharm.2018.11.015. Epub 2018 Nov 15. Neuropharmacology. 2019. PMID: 30448421

8

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

Berman RM, Marcus RN, Swanink R, McQuade RD, Carson WH, Corey-Lisle PK, Khan A. Berman RM, et al. J Clin Psychiatry. 2007 Jun;68(6):843-53. doi: 10.4088/jcp.v68n0604. J Clin Psychiatry. 2007. PMID: 17592907 Clinical Trial.

9

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.

El-Khalili N, Joyce M, Atkinson S, Buynak RJ, Datto C, Lindgren P, Eriksson H. El-Khalili N, et al. Int J Neuropsychopharmacol. 2010 Aug;13(7):917-32. doi: 10.1017/S1461145710000015. Epub 2010 Feb 23. Int J Neuropsychopharmacol. 2010. PMID: 20175941 Free article. Clinical Trial.

10

Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?

Peckham AM, De La Cruz A, Dufresne RL. Peckham AM, et al. Ment Health Clin. 2018 Jun 29;8(4):175-183. doi: 10.9740/mhc.2018.07.175. eCollection 2018 Jul. Ment Health Clin. 2018. PMID: 30155392 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year